The effect of azithromycin on reactive oxygen species in rosacea


Bakar O., DEMİRÇAY Z., YÜKSEL M., HAKLAR G., SANİSOĞLU Y.

CLINICAL AND EXPERIMENTAL DERMATOLOGY, cilt.32, sa.2, ss.197-200, 2007 (SCI-Expanded) identifier identifier identifier

Özet

Background: Recent evidence suggests that inflammation in rosacea is associated with generation of reactive oxygen species (ROS) that are released by inflammatory cells. The efficacy of current therapeutic agents for rosacea such as tetracyclines and metronidazole has also been attributed to their antioxidant properties. Recently, a macrolide antibiotic, azithromycin, has been found to be an effective alternative in the treatment of rosacea.